<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045550">
  <TermName>interleukin-4 PE38KDEL cytotoxin</TermName>
  <TermPronunciation>(in-ter-LOO-kin ... SY-toh-TOK-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. Interleukin-4 PE38KDEL cytotoxin is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL immunotoxin and NBI-3001.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000705578" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-4 PE38KDEL cytotoxin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000705579" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-4 PE38KDEL citotoxina&quot;" language="es" id="_4"/>
  <SpanishTermName>interleucina-4 PE38KDEL citotoxina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Está hecha de una combinación de interleucina 4 con una toxina bacteriana. La interleucina-4 PE38KDEL citotoxina es un tipo de proteína quimérica recombinante. También se llama interleucina-4 PE30KDEL inmunotoxina y NBI-3001.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-04-06</DateLastModified>
</GlossaryTerm>
